These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15898990)

  • 21. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
    Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R
    Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoallergens for allergen-specific immunotherapy by directed molecular evolution of mite group 2 allergens.
    Gafvelin G; Parmley S; Neimert-Andersson T; Blank U; Eriksson TL; van Hage M; Punnonen J
    J Biol Chem; 2007 Feb; 282(6):3778-87. PubMed ID: 17170112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects.
    Thoms F; Jennings GT; Maudrich M; Vogel M; Haas S; Zeltins A; Hofmann-Lehmann R; Riond B; Grossmann J; Hunziker P; Fettelschoss-Gabriel A; Senti G; Kündig TM; Bachmann MF
    J Allergy Clin Immunol; 2019 Jul; 144(1):193-203. PubMed ID: 31056187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
    Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
    Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential therapeutic recombinant proteins comprised of peptides containing recombined T cell epitopes.
    Rogers BL; Bond JF; Craig SJ; Nault AK; Segal DB; Morgenstern JP; Chen MS; Bizinkauskas CB; Counsell CM; Lussier AM
    Mol Immunol; 1994 Sep; 31(13):955-66. PubMed ID: 7521933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy.
    Kussebi F; Karamloo F; Rhyner C; Schmid-Grendelmeier P; Salagianni M; Mannhart C; Akdis M; Soldatova L; Markovic-Housley Z; Von Beust BR; Kündig T; Kemeny DM; Blaser K; Crameri R; Akdis CA
    J Allergy Clin Immunol; 2005 Feb; 115(2):323-9. PubMed ID: 15696088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploiting the avian immunoglobulin system to simplify the generation of recombinant antibodies to allergenic proteins.
    Finlay WJ; deVore NC; Dobrovolskaia EN; Gam A; Goodyear CS; Slater JE
    Clin Exp Allergy; 2005 Aug; 35(8):1040-8. PubMed ID: 16120086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of recombinant stable house dust mite allergen Der p 3 molecules for component-resolved diagnosis and specific immunotherapy.
    Bouaziz A; Walgraffe D; Bouillot C; Herman J; Foguenne J; Gothot A; Louis R; Hentges F; Jacquet A; Mailleux AC; Chevigné A; Galleni M; Adam E; Dumez ME
    Clin Exp Allergy; 2015 Apr; 45(4):823-34. PubMed ID: 25406386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Native and recombinant Fel dI as probes into the relationship of allergen structure to human IgE immunoreactivity.
    Bond JF; Brauer AW; Segal DB; Nault AK; Rogers BL; Kuo MC
    Mol Immunol; 1993 Nov; 30(16):1529-41. PubMed ID: 8232338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cat lipocalin Fel d 7 and its cross-reactivity with the dog lipocalin Can f 1.
    Apostolovic D; Sánchez-Vidaurre S; Waden K; Curin M; Grundström J; Gafvelin G; Cirkovic Velickovic T; Grönlund H; Thomas WR; Valenta R; Hamsten C; van Hage M
    Allergy; 2016 Oct; 71(10):1490-5. PubMed ID: 27289080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure of the dog allergen Can f 6 and structure-based implications of its cross-reactivity with the cat allergen Fel d 4.
    Yamamoto K; Ishibashi O; Sugiura K; Ubatani M; Sakaguchi M; Nakatsuji M; Shimamoto S; Noda M; Uchiyama S; Fukutomi Y; Nishimura S; Inui T
    Sci Rep; 2019 Feb; 9(1):1503. PubMed ID: 30728436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In search of a vaccine for mouse allergy: significant reduction of Mus m 1 allergenicity by structure-guided single-point mutations.
    Ferrari E; Breda D; Longhi R; Vangelista L; Nakaie CR; Elviri L; Casali E; Pertinhez TA; Spisni A; Burastero SE
    Int Arch Allergy Immunol; 2012; 157(3):226-37. PubMed ID: 22041937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and isolation of a Fel d 1-like molecule as a major rabbit allergen.
    Hilger C; Kler S; Arumugam K; Revets D; Muller CP; Charpentier C; Lehners C; Morisset M; Hentges F
    J Allergy Clin Immunol; 2014 Mar; 133(3):759-66. PubMed ID: 23763973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two newly identified cat allergens: the von Ebner gland protein Fel d 7 and the latherin-like protein Fel d 8.
    Smith W; O'Neil SE; Hales BJ; Chai TL; Hazell LA; Tanyaratsrisakul S; Piboonpocanum S; Thomas WR
    Int Arch Allergy Immunol; 2011; 156(2):159-70. PubMed ID: 21576986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of specific immune responses by chemical and structural modifications of allergens.
    Akdis CA; Blaser K
    Int Arch Allergy Immunol; 2000 Apr; 121(4):261-9. PubMed ID: 10828716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections.
    Senti G; Crameri R; Kuster D; Johansen P; Martinez-Gomez JM; Graf N; Steiner M; Hothorn LA; Grönlund H; Tivig C; Zaleska A; Soyer O; van Hage M; Akdis CA; Akdis M; Rose H; Kündig TM
    J Allergy Clin Immunol; 2012 May; 129(5):1290-6. PubMed ID: 22464647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A chimeric human-cat Fcgamma-Fel d1 fusion protein inhibits systemic, pulmonary, and cutaneous allergic reactivity to intratracheal challenge in mice sensitized to Fel d1, the major cat allergen.
    Terada T; Zhang K; Belperio J; Londhe V; Saxon A
    Clin Immunol; 2006 Jul; 120(1):45-56. PubMed ID: 16473552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epitope peptides and immunotherapy.
    Tanabe S
    Curr Protein Pept Sci; 2007 Feb; 8(1):109-18. PubMed ID: 17305564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A hypoallergenic variant of Der p 1 as a candidate for mite allergy vaccines.
    Walgraffe D; Mattéotti C; El Bakkoury M; Garcia L; Marchand C; Bullens D; Vandenbranden M; Jacquet A
    J Allergy Clin Immunol; 2009 May; 123(5):1150-6. PubMed ID: 19152967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of allergen-specific desensitization.
    Uermösi C; Beerli RR; Bauer M; Manolova V; Dietmeier K; Buser RB; Kündig TM; Saudan P; Bachmann MF
    J Allergy Clin Immunol; 2010 Aug; 126(2):375-83. PubMed ID: 20624641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.